|
Match
|
Document |
Document Title |
|
|
7638550 |
Pyrrolic derivatives with histone deacetylase inhibitory activity
The invention describes new compounds derived from formula I pyrroles, methods for obtaining them and their application as drugs in pharmaceutical compositions for the treatment of cancer due to...
|
|
|
7625932 |
Pyrrole and pyrazole derivatives as potentiators of glutamate receptors
The present invention relates to pyrrole and pyrazole compounds of formula (I) and their pharmaceutically acceptable salts, and further relates to their use in treating schizophrenia, cognitive...
|
|
|
7608592 |
HCV inhibitors
The present invention is directed to compounds that are antiviral agents. Specifically the compounds of the present invention inhibit replication of HCV and are therefore useful in treating...
|
|
|
7601752 |
Pyrrolidine derivatives
The invention is concerned with novel pyrrolidine derivatives of formula (I)
wherein X, Y, R 1 , R 2 and R 3 are as defined in the description and in the claims, as well as physiologically...
|
|
|
7589119 |
Methods for treating or preventing metastatic cancer using benzopyranone compounds
This invention relates to Benzopyranone Compounds, compositions comprising a Benzopyranone Compound and methods for treating or preventing cancer or inhibiting the growth of a cancer cell or...
|
|
|
7585882 |
Phosphodiesterase 4 inhibitors
Selective PDE4 inhibition is achieved by novel compounds, e.g., 4-(substituted-phenyl)-2-pyrrolidinone compounds. The compounds of the present invention are of formula I:
wherein R 1 , R 2 ,...
|
|
|
7582749 |
Photochromic compounds
Various non-limiting embodiments disclosed herein relate generally to photochromic compounds, which may be thermally reversible or non-thermally reversible, and articles made therefrom. Other...
|
|
|
7576102 |
Biaryl substituted nitrogen containing heterocycle inhibitors of LTA4H for treating inflammation
The present invention relates to a chemical genus of biaryl substituted nitrogen-attached heterocycles that are inhibitors of LTA4H (leukotriene A4 hydrolase). The compounds have the general...
|
|
|
7572824 |
Methods for minimizing thioamide impurities
Methods for minimizing the formation of thioamide compounds using decoy agents during reactions, such as thionations of carbonyl compounds containing nitrile groups, and the products thereby are...
|
|
|
7563910 |
Heterocyclic cannabinoid receptor antagonists
The present invention relates to compounds of formula I
and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prophylaxis of diseases which are...
|
|
|
7553861 |
Dipeptidyl peptidase-IV inhibitors
The present invention relates generally to pyrrolidine and thiazolidine DPP-IV inhibitor compounds. The present invention also provides synthetic methods for preparation of such compounds, methods...
|
|
|
7550487 |
Pyrrolidine-3,4-dicarboxamide derivatives
The invention is concerned with novel pyrrolidine-3,4-dicarboxamide derivatives of formula (I)
wherein R 1 to R 9 and X are as defined in the description and in the claims, as well as...
|
|
|
7547694 |
Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions
The present invention relates to the CGRP antagonists of general formula
wherein A and R 1 to R 3 are defined as in claim 1 , the tautomers, the diastereomers, the enantiomers, the hydrates...
|
|
|
7538138 |
Amines as histamine-3 receptor ligands and their therapeutic applications
Compounds of formula (I)
or a pharmaceutically acceptable salts or prodrug thereof which are useful for the modulation of the histamine-3 receptors in mammals and which are useful for the...
|
|
|
7534810 |
Salt forms of [R—(R*,R*)]-2-(4-fluorophenyl)-β, δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid
Novel salt forms of [R-(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylet
hyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptano
ic acid characterized by their X-ray powder diffraction...
|
|
|
7528156 |
Compounds
The invention provides compounds of general formula (D wherein m, n, Q, Z1, Z2, R1, R2, R3, R4, R5, R6, R7, and R8 are as defined in the specification, processes for their preparation,...
|
|
|
7521470 |
Factor Xa inhibitors
The present invention is directed to compounds represented by Formula I and pharmaceutically acceptable salts, solvates, hydrates, and prodrugs thereof which are inhibitors of Factor Xa. The...
|
|
|
RE40667 |
[R-(R*R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid, its lactone form and salts thereof
[R-(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-((1-methyle
thyl)-3-phenyl-4-[(phenylamino)-carbonyl)]-1H-pyrrole-1-hept
anoic acid or...
|
|
|
7504243 |
Methods for the production of biliverdin
The present invention relates to compositions and methods for the production of biliverdin. In particular, the invention concerns methods for producing biliverdin in yeast, especially Candida...
|
|
|
7482475 |
Therapeutic lactams
Disclosed herein is a compound having a structure
Therapeutic methods, compositions, and medicaments related thereto are also disclosed.
|
|
|
7476747 |
Substituted gamma lactams as therapeutic agents
A compound comprising
or a pharmaceutically acceptable salt, prodrug, or a metabolite thereof is disclosed herein. Y, A, and B are as described herein.
Methods, compositions, and medicaments...
|
|
|
7456164 |
3- or 4-monosubtituted phenol and thiophenol derivatives useful as H3 ligands
The invention relates to 3- or 4-monosubstituted phenol and thiophenol derivatives of formula (I) and to processes for the preparation of, intermediates used in the preparation of, compositions...
|
|
|
7456209 |
IAP binding compounds
IAP binding molecules and compositions including these are disclosed. The IAP binding molecules interact with IAPs (inhibitor of apoptosis proteins) in cells and may be used to modify apoptosis in...
|
|
|
RE40525 |
Hepatitis C inhibitor tri-peptides
A racemate diastereoisomer and optical isomer of a compound of formula (I):
wherein B is H, a C 6 or C 10 aryl, C 7-16 aralkyl; Het or (lower alkyl)-Het, all of which may be optionally...
|
|
|
7425575 |
Spirocyclic 3-phenyl-3-substituted 4-ketolactams and 4-ketolactones
The present invention relates to novel phenyl-substituted 4-ketolactams and -lactones of the formula (I)
in which
A, B, Q, G, W, X, Y, Z and R 3 are as defined above, to processes and...
|
|
|
7423061 |
Substitute thiophenes and uses thereof
This invention relates to novel compounds having the structural formula (I) and to their pharmaceutical salts, compositions and methods of use. These novel compounds provide a treatment or...
|
|
|
7417062 |
Substituted arylamides
Substituted benzamide compounds are provided along with methods for the use of those compounds for treating cancer.
|
|
|
7414141 |
Process and intermediate compounds useful in the preparation of statins, particularly atorvastatin
There is provided a process for the preparation of a compound of formula (7) or salts thereof: wherein R 1 represents a hydrogen or a hydrocarbyl group, R 2 represents a hydrogen or substituent...
|
|
|
7399773 |
Process for the synthesis of 5-(4-fluorophenyl)-1-[2-((2R,4R)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxylic acid and phenylamide
An improved process for the preparation of 5-(4-fluorophenyl)-1-[2-((2R,4R)-4-hydroxy-6-oxo-tetrahydro-
pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxy
lic acid phenylamide by a novel...
|
|
|
7396851 |
Heterocyclic and benzoheterocyclic polyamides structurally related to the natural antibiotic distamycin A for the treatment of β-thalassaemia
The invention relates to the use of structural analogues of distamycin having the general formula (I), (II), (III), (IV) or (V) or their pharmaceutically acceptable salts, for the preparation of a...
|
|
|
7388007 |
Gamma-lactams as beta-secretase inhibitors
There is provided a series of novel substituted gamma-lactams of Formula (I)
or a stereoisomer; or a pharmaceutically acceptable salt thereof, wherein R 1 , R 2 , R 4 , R 5 and R 6 as defined...
|
|
|
7381741 |
3-amino-2-phenylpyrrolidine derivatives
3-amino-2-phenylpyrrolidine compounds useful as NK-1 antagonists, with pharmaceutical compositions and methods of treatment comprising same, are disclosed.
|
|
|
7378436 |
Compounds
A compound of Formula (I)
and pharmaceutically and/or veterinarily acceptable derivatives thereof, wherein R 1 is H, C 1-6 alkyl, —C(X)Y, C 3-8 cycloalkyl, aryl, het, aryl-C 1-4 alkyl or...
|
|
|
7365092 |
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
The present invention relates to compounds of formula I:
or pharmaceutically acceptable salts thereof that inhibit serine protease activity, particularly the activity of hepatitis C virus...
|
|
|
7361771 |
Process for the synthesis of 5-(4-fluorophenyl)-1-[2-((2R,4R)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide
An improved process for the preparation of 5-(4-fluorophenyl)-1-[2-((2R,4R)-4-hydroxy-6-oxo-tetrahydro-
pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxy
lic acid phenylamide by a novel...
|
|
|
7361755 |
Transition-metal-catalyzed process for the conversion of alkenes to sterically hindered substituted n-alkoxyamines
This invention pertains to a novel process for preparing sterically hindered N-substituted alkyloxyamines from alkenes by the transition-metal-catalyzed reaction of a intermediate alkylborane with...
|
|
|
7358273 |
Inhibitors of caspases
The present invention relates to novel classes of compounds which are caspase inhibitors, in particular interleukin-1β converting enzyme (“ICE”) inhibitors. This invention also relates to...
|
|
|
7358274 |
Methods for treating or preventing cancer using Benzopyranone Compounds
This invention relates to Benzopyranone Compounds, compositions comprising a Benzopyranone Compound and methods for treating or preventing cancer or inhibiting the growth of a cancer cell or...
|
|
|
7348346 |
Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
The present invention relates to compounds of formula (I),
which inhibit dipeptidyl peptidase IV (DPP-IV) and are useful for the prevention or treatment of diabetes, especially type II...
|
|
|
7329762 |
Prodrugs of mitotic kinesin inhibitors
The present invention relates to phosphate ester prodrugs of dihydropyrrole compounds that are useful for treating cellular proliferative diseases, for treating disorders associated with KSP...
|
|
|
7319132 |
Polymer compounds containing oxetane and maleimide functionality
Polymeric compounds containing an oxetane functionality and a maleimide functionality have the structure
in which polymer is a polymeric backbone, m and n are integers from 2 to 500, R 1 is...
|
|
|
7319148 |
Combinatorial production of nucleotide and nucleoside (XiTP) analogues
The invention concerns novel nucleotide analogues comprising a reactive hydrazide function used as initial synthons for preparing compounds (formula I) capable of inducing mutations or capable of...
|
|
|
7317064 |
Phenolic resin systems for fiber reinforced composite manufacture
The invention includes formulations useful for creating reinforced composites based on 1) novolac resin compositions, and, 2) non-formaldehyde hardeners, as well as processes for manufacturing...
|
|
|
7317063 |
Phenolic resins
The invention herein disclosed comprises the use of oxazolidines, nitroalcohols, nitroamines, aminonitroalcohols, imines, hexahydropyrimidines, nitrones, hydroxylamines, nitro-olefins and...
|
|
|
7312336 |
Compounds with analgesic effect
Compounds of general formula (I)
are disclosed and claimed in the present application, as well as their pharmaceutically acceptable salts, pharmaceutical compositions comprising the novel...
|
|
|
7304087 |
1-acyl-pyrrolidine derivatives for the treatment of viral infections
Anti-viral agents of Formula (I)
wherein:
A represents hydroxy; D represents aryl or heteroaryl; E represents hydrogen, C 1-6 alkyl, aryl, heteroaryl or heterocyclyl; G represents hydrogen or...
|
|
|
7282510 |
Small molecule inhibitors of rotamase enzyme activity
This invention relates to neurotrophic N-glyoxyl-prolyl ester compounds having an affinity for FKBP-type immunophilins, their preparation and use as inhibitors of the enzyme activity associated...
|
|
|
7276531 |
G-lactam derivatives as prostaglandin agonists
A gamma-lactam diene of Formula I:
which is particularly useful as a medicament for the treatment of various disorders such as asthma, hypertension, osteoporosis, sexual dysfunction and...
|
|
|
7259179 |
Kinase inhibitors
A compound of the general formula:
or pharmaceutically acceptable salts, hydrates, solvates, crystal forms or diastereomers thereof is described. A method of treating protein kinase-associated...
|
|
|
7250519 |
Method for the production of arylamines
The invention relates to a method for the production of tertiary amines by reaction of secondary amines with aromatics or heteroaromatics in the presence of a base, a nickel or palladium compound...
|